ABOPM Hero

Advancing Science & Standards

The Professional Standard for
Precision Medicine

A modern board for a new era of medicine — advancing education, certification, and clinical standards for physicians practicing genomics-driven, data-informed, individualized care.

Become a Member Get Certified

MD & DO Physicians Only

13+ Specialty Modules

CME Accredited Programs

Evidence Based Standards

Where precision becomes professional standard.

Setting the benchmark for next-generation clinical practice.

Clinical Focus Areas

Genomics Biology-informed care

AI + Data Clinical intelligence

Standards Professional governance

Certified Board recognition

Explore Membership Options View Certification Pathways Browse Clinical Resources

Recognized For

Physician-Led Governance Directed by practicing MDs & DOs

Evidence-Based Curriculum Peer-reviewed clinical standards

CME Accredited Programs Continuing medical education credits

MD & DO Exclusive Restricted to licensed physicians

Multi-Specialty Certification 13+ precision medicine pathways

Department Spotlight

Precision Oncology
Department

The ABOPM Precision Oncology Department trains physicians to integrate tumor genomics, liquid biopsy, immunoprofiling, and targeted therapeutics into individualized treatment strategies — moving beyond population averages to treat each cancer as the unique disease it is.

Visit Department Page

$560B

Oncology Market by 2030

100%

Tumors Have a Molecular Story

Board

Certified Framework

Multi

Disciplinary Faculty

Department Director

Dr. Emre Baser, MD

Director of Precision Oncology · ABOPM

Dr. Baser leads initiatives at the intersection of clinical oncology, tumor genomics, and precision therapeutics. He spearheads ABOPM's board-certified frameworks for biomarker-driven treatment selection, resistance mechanism interpretation, liquid biopsy monitoring, and adaptive precision therapy across solid tumors and hematologic malignancies.

Tumor Genomics Liquid Biopsy Targeted Therapy Immunoprofiling ctDNA Analysis

Core Clinical Focus Areas

Comprehensive Genomic Profiling

Somatic mutation analysis, copy number alterations, gene fusions, and mutational signatures across all tumor types.

Liquid Biopsy & ctDNA Monitoring

Real-time treatment response monitoring, minimal residual disease detection, and early resistance identification.

Immune Microenvironment Analysis

TMB, MSI status, PD-L1 expression, and TIL infiltration to identify immunotherapy responders.

Resistance Mechanism Mapping

Identifying acquired resistance pathways and adapting therapeutic strategy before clinical progression.

What Board Certification Equips You To Do

Interpret Genomic Profiles

Identify actionable somatic mutations, copy number alterations, and gene fusions across every tumor site.

Lead Molecular Tumor Boards

Guide institutional precision cancer programs and complex genomic treatment decisions.

Monitor with Liquid Biopsy

Use ctDNA analysis to detect minimal residual disease and adapt therapy in real time.

Select Immunotherapy Precisely

Identify which patients respond to checkpoint inhibitors vs. combination or alternative immune strategies.

Every tumor has a molecular story.
Are you trained to read it?

Explore the Department Get Certified

Built on the Science of Precision Medicine

A powerful clinical framework for
individualized care.

Precision medicine can no longer rely on one-size-fits-all care. ABOPM certification is grounded in the disciplines that make modern medicine more targeted, more predictive, and more biologically aligned.

The Right Patient Identify meaningful biological variation across individuals and populations.

The Right Drug Translate data into smarter therapy selection and clinical precision.

The Right Time Use biomarkers and systems insight to intervene with greater accuracy.

The Precision Medicine Standard

Why It Matters Now

Clinical Application

The three pillars of a modern clinical foundation.

These pillars work together to move medicine beyond generalized treatment and toward a rigorous model of care that integrates biology, computation, and clinical decision-making.

Multi-Omics

Harness genomic, transcriptomic, proteomic, and metabolomic data to understand individual disease risk, biology, and treatment response with greater depth and specificity.

Learn More

Systems Biology

Move beyond isolated pathways to understand disease as a dynamic system, enabling prediction, prevention, and precision intervention across interconnected biological networks.

Learn More

Clinical Medicine

Apply clinically grounded models to uncover disease drivers, biomarkers, and personalized therapeutic targets, connecting biological complexity to actionable patient care.

Learn More

Precision medicine is not simply about treating disease. It is about matching biology, risk, and therapeutic strategy with greater clinical responsibility. ABOPM helps define that standard through research, education, governance, and certification.

ABOPM — Stats Section

Why Precision Medicine Matters

Precision Medicine Is Reshaping
the Future of Healthcare

Rapid growth in genomics, diagnostics, and AI-driven healthcare is creating a defining opportunity for physicians trained in precision medicine — across certification, research, education, and governance.

Leadership Pillar

Certification

Advance standards, validate expertise, and recognize physicians prepared for precision medicine practice.

Leadership Pillar

Research

Drive evidence-based innovation through genomics, clinical investigation, and translational discovery.

Leadership Pillar

Education

Equip physicians with modern training in data-informed, individualized, and biology-guided care.

Leadership Pillar

Governance

Shape ethical frameworks, institutional quality, and responsible oversight for the future of medicine.

2025 Market

$0B

Global precision medicine market value.

2026 Market

$0B

Accelerated expansion in genomic diagnostics.

2031 Projection

$0B

Market expected to nearly double globally.

Growth Rate

0%

Projected CAGR from 2026–2031.

Precision medicine is projected to exceed $237B globally by 2031, powered by genomics, multi-omics diagnostics, AI-guided clinical decisions, and the growing need for physicians equipped to lead this transformation.

Become a Member Get Certified

Clinical Impact Signals

Relative Risk by Cancer Type

0

Colon
Cancer

0

Prostate
Cancer

0

Breast
Cancer

The Physician Opportunity

Precision medicine is no longer emerging — it is becoming foundational. The physicians who lead in certification, research, education, and governance will define how personalized care is delivered, evaluated, and trusted worldwide.

Genomics Department · ABOPM

Shaping the Future
of Precision Medicine

As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.

The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.

Explore Certification → Get Involved

Featured Insights

Insights Shaping
Precision Medicine

Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.

Multi-Omics Clinical Innovation Precision Prevention Physician Leadership

Case Study: Using Genomic Data to Guide Treatment Decisions

Learn how genomic profiling identified an EGFR mutation and guided targeted therapy selection in a real-world precision oncology case. ...more

Precision Medicine in Action

June 11, 2026•8 min read

Liquid Biopsy and Early Cancer Detection: Promise and Limitations

Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring. ...more

Precision Oncology

June 05, 2026•9 min read

Polygenic Risk Scores and the Genomic Data Gap: Promise, Limitations, and Equity in Precision Medicine

Polygenic risk scores may transform disease prediction, but gaps in genomic diversity continue to limit equity, accuracy, and access in precision medicine across global populations. ...more

Population Precision

May 26, 2026•9 min read